Nature brings new avenues to the therapy of central nervous system diseases—An overview of possible treatments derived from natural products

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Science China Life Sciences

• Publication date

  2019-08-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11427-019-9587-yPMID 31444682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation.

  2019cited by this paper
• Cannabidiol as a suggested candidate for treatment of autism spectrum disorder

  2019cited by this paper
• Antidepressant effect of helicid in chronic unpredictable mild stress model in rats.

  2019cited by this paper
• Multiple sclerosis

  2018cited by this paper
• Suanzaoren Formulae for Insomnia: Updated Clinical Evidence and Possible Mechanisms

  2018cited by this paper
• Lobeline Effects on Cognitive Performance in Adult ADHD

  2018cited by this paper
• Protective Effect of Hyperforin on β Amyloid Protein Induced Apoptosis in PC12 Cells and Colchicine Induced Alzheimer's Disease: An Anti-oxidant and Anti-inflammatory Therapy.

  2018cited by this paper
• Magnolol abrogates chronic mild stress‐induced depressive‐like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice

  2018cited by this paper
• A Review on Central Nervous System Effects of Gastrodin

  2018cited by this paper
• Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer’s disease and mild cognitive impairment

  2018cited by this paper
• Budlein A, a Sesquiterpene Lactone From Viguiera robusta, Alleviates Pain and Inflammation in a Model of Acute Gout Arthritis in Mice

  2018cited by this paper
• Autism spectrum disorder

  2018cited by this paper
• Riparin II ameliorates corticosterone‐induced depressive‐like behavior in mice: Role of antioxidant and neurotrophic mechanisms

  2018cited by this paper
• Addressing the Issue of Tetrodotoxin Targeting

  2018cited by this paper
• Geniposide Increases Unfolded Protein Response-Mediating HRD1 Expression to Accelerate APP Degradation in Primary Cortical Neurons

  2018cited by this paper
• Anticonvulsant activities of α-asaronol ((E)-3′-hydroxyasarone), an active constituent derived from α-asarone

  2018cited by this paper
• Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.

  2018cited by this paper
• Saikosaponin A modulates remodeling of Kv4.2-mediated A-type voltage-gated potassium currents in rat chronic temporal lobe epilepsy

  2018cited by this paper
• Cannabidiol for Epilepsy: New Hope on the Horizon?

  2018cited by this paper
• Naringin in a combined therapy with phenytoin on pentylenetetrazole-induced kindling in rats.

  2018cited by this paper
• New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders

  2018cited by this paper
• Protective effects of γ-mangostin on 6-OHDA-induced toxicity in SH-SY5Y cells.

  2018cited by this paper
• Cannabis for the Treatment of Epilepsy: an Update

  2018cited by this paper
• Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene.

  2018cited by this paper
• Resveratrol exerts a protective effect in chronic unpredictable mild stress–induced depressive-like behavior: involvement of the AKT/GSK3β signaling pathway in hippocampus

  2018cited by this paper
• Flavones‐bound in benzodiazepine site on GABAA receptor: Concomitant anxiolytic‐like and cognitive‐enhancing effects produced by Isovitexin and 6‐C‐glycoside‐Diosmetin

  2018cited by this paper
• Echinacoside, an Inestimable Natural Product in Treatment of Neurological and other Disorders

  2018cited by this paper
• Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis.

  2018cited by this paper
• Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer's disease: Effects against scopolamine and streptozotocin‐induced cognitive dysfunctions

  2018cited by this paper
• Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?

  2018cited by this paper
• Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice

  2018cited by this paper
• Resveratrol, pterostilbene, and dementia

  2018cited by this paper
• Cannabinoids for Treatment of MS Symptoms: State of the Evidence

  2018cited by this paper
• Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice

  2018cited by this paper
• Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle‐aged Alzheimer model mice

  2017cited by this paper
• Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease

  2017cited by this paper
• Ferulic acid inhibits neuro‐inflammation in mice exposed to chronic unpredictable mild stress

  2017cited by this paper
• Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine

  2017cited by this paper
• Zinc Protects Oxidative Stress-Induced RPE Death by Reducing Mitochondrial Damage and Preventing Lysosome Rupture

  2017cited by this paper
• Pellitorine, an extract of Tetradium daniellii, is an antagonist of the ion channel TRPV1.

  2017cited by this paper
• Synthesis and SAR study of novel sarsasapogenin derivatives as potent neuroprotective agents and NO production inhibitors.

  2017cited by this paper
• n‐butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis

  2017cited by this paper
• A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease

  2017cited by this paper
• HPLC-Based Activity Profiling for GABAA Receptor Modulators in Extracts: Validation of an Approach Utilizing a Larval Zebrafish Locomotor Assay.

  2017cited by this paper
• Baicalein as a potent neuroprotective agent: A review.

  2017cited by this paper
• Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: Review on the basis of in vitro and in vivo studies in rodents and humans

  2017cited by this paper
• Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity

  2017cited by this paper
• Baicalein blocks α-synuclein secretion from SN4741 cells and facilitates α-synuclein polymerization to big complex.

  2017cited by this paper
• Ligustilide Relieves Complete Freund's Adjuvant-induced Mechanical Hyperalgesia through Inhibiting the Activation of Spinal c-Jun N-terminal Kinase/c-Jun Pathway in Rats

  2017cited by this paper
• Anti‐inflammatory and analgesic activity of carnosol and carnosic acid in vivo and in vitro and in silico analysis of their target interactions

  2017cited by this paper
• α‐Spinasterol: a COX inhibitor and a transient receptor potential vanilloid 1 antagonist presents an antinociceptive effect in clinically relevant models of pain in mice

  2017cited by this paper
• Protective effect of naringin on pentylenetetrazole (PTZ)-induced kindling; possible mechanisms of antikindling, memory improvement, and neuroprotection.

  2017cited by this paper
• Protective effect of Nrf2–ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model

  2017cited by this paper
• Effect of Chinese Herbal Medicine on Alzheimer's Disease.

  2017cited by this paper
• (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis

  2017cited by this paper
• Antidepressant-like activity of icariin mediated by group I mGluRs in prenatally stressed offspring.

  2017cited by this paper
• Koumine exhibits anxiolytic properties without inducing adverse neurological effects on functional observation battery, open-field and Vogel conflict tests in rodents

  2017cited by this paper
• Amentoflavone protects dopaminergic neurons in MPTP‐induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways

  2017cited by this paper
• Cannabinoids and Pain: Sites and Mechanisms of Action.

  2017cited by this paper
• An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds.

  2017cited by this paper
• Myricetin ameliorates scopolamine-induced memory impairment in mice via inhibiting acetylcholinesterase and down-regulating brain iron.

  2017cited by this paper
• Helicid alleviates pain and sleep disturbances in a neuropathic pain‐like model in mice

  2017cited by this paper
• Longistyline C acts antidepressant in vivo and neuroprotection in vitro against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK pathway in PC12 cells

  2017cited by this paper
• Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway

  2017cited by this paper
• Maslinic acid ameliorates NMDA receptor blockade‐induced schizophrenia‐like behaviors in mice

  2017cited by this paper
• Cannabis for Pain and Headaches: Primer

  2017cited by this paper
• Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human

  2017cited by this paper
• Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease

  2017cited by this paper
• Pinitol alleviates systemic inflammatory cytokines in human obesity by a mechanism involving unfolded protein response and sirtuin 1.

  2017cited by this paper
• α‐Mangostin decreases β‐amyloid peptides production via modulation of amyloidogenic pathway

  2017cited by this paper
• Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds.

  2017cited by this paper
• Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets

  2017cited by this paper
• Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease

  2017cited by this paper
• Puerarin inhibits β‑amyloid peptide 1‑42‑induced tau hyperphosphorylation via the Wnt/β‑catenin signaling pathway.

  2017cited by this paper
• Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis.

  2017cited by this paper
• Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders

  2017cited by this paper
• Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic–Pituitary–Adrenal Axis Function and Activating BDNF Signaling Pathway

  2017cited by this paper
• Neuroprotective effects of liquiritin on cognitive deficits induced by soluble amyloid-β1–42 oligomers injected into the hippocampus

  2016cited by this paper
• 3,4,5-Trimethoxycinnamic acid, one of the constituents of Polygalae Radix exerts anti-seizure effects by modulating GABAAergic systems in mice.

  2016cited by this paper
• Cytisine, a Partial Agonist of α4β2 Nicotinic Acetylcholine Receptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like Behaviors

  2016cited by this paper
• Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease.

  2016cited by this paper
• The rapid antidepressant and anxiolytic-like effects of YY-21 involve enhancement of excitatory synaptic transmission via activation of mTOR signaling in the mPFC.

  2016cited by this paper
• TRPs and pain

  2016cited by this paper
• Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice

  2016cited by this paper
• Selective Serotonin Reuptake Inhibitors for Fibromyalgia.

  2016cited by this paper
• Potentiation of decursinol angelate on pentobarbital-induced sleeping behaviors via the activation of GABAA-ergic systems in rodents

  2016cited by this paper
• The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi-target effect.

  2016cited by this paper
• Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells

  2016cited by this paper
• Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer’s Disease Cell Model via Upregulation of MicroRNA-9

  2016cited by this paper
• Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice

  2016cited by this paper
• Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations.

  2016cited by this paper
• Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.

  2016cited by this paper
• Piperine potentiates the effects of trans-resveratrol on stress-induced depressive-like behavior: involvement of monoaminergic system and cAMP-dependent pathway

  2016cited by this paper
• Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade

  2016cited by this paper
• Sulforaphane Treatment of Young Men with Autism Spectrum Disorder.

  2016cited by this paper
• Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.

  2016cited by this paper
• Capsaicin and Its Role in Chronic Diseases.

  2016cited by this paper
• Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice.

  2016cited by this paper
• Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists.

  2016cited by this paper
• Effects of an ethanol extract and the diterpene, xylopic acid, of Xylopia aethiopica fruits in murine models of musculoskeletal pain

  2016cited by this paper

• A Machine Learning Approach to Evaluating the Impact of Natural Oils on Alzheimer’s Disease Progression

  2024cites this paper
• Digirseophene A promotes recovery in injured developing cerebellum via AMPK/AKT/GSK3β pathway-mediated neural stem cell proliferation.

  2024cites this paper
• The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives

  2024cites this paper
• Pterostilbene as a Therapeutic Alternative for Central Nervous System Disorders: A Review of the Current Status and Perspectives.

  2023cites this paper
• An integrated targeted metabolomics and network pharmacology approach to exploring the mechanism of ellagic acid against sleep deprivation-induced memory impairment and anxiety

  2023cites this paper
• Mechanism of ligusticum cycloprolactam against neuroinflammation based on network pharmacology and experimental verification

  2023cites this paper
• Tibetan medicine Ruyi Zhenbao Pill ameliorates neuropathic pain by inhibiting the CXCL10-CXCR3 pathway in spinal cord of spinal nerve ligation model.

  2023cites this paper
• A Comprehensive Review of the Pharmacological Effects of Genus Ferula on Central Nervous System Disorders.

  2023cites this paper
• Investigation of the “Nose-to-Brain” Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability

  2022cites this paper
• Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress.

  2022cites this paper
• Baicalein-functionalized collagen scaffolds direct neuronal differentiation toward enhancing spinal cord injury repair.

  2022cites this paper
• Application and advantages of zebrafish model in the study of neurovascular unit.

  2021cites this paper
• Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update

  2021cites this paper
• Application of carbohydrates in approved small molecule drugs: A review.

  2021cites this paper
• Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus.

  2020cites this paper
• Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

  2020cites this paper
• Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach

  2020cites this paper
• Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential

  2020cites this paper
• Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.

  2020cites this paper
• α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome

  2020cites this paper
• Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics.

  2020cites this paper
• Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach

  2019cites this paper